DFINE Star Tumor Ablation System Shows Promise as Spinal Tumor Therapy

DFINE, minimally invasive radiofrequency therapy company, has announced the results of two clinical studies of its STAR Tumor Ablation System, which demonstrated the system’s ability to provide pain relief from vertebral tumors.

Advertisement

Jack Jennings, MD, PhD, director of musculoskeletal and spine intervention at the Washington University School of Medicine in St. Louis, led the first study. Robert Ryu, MD, professor of radiology at the Feinberg School of Medicine, Northwestern University in Chicago, led the second study.

The study results were presented at the Society of Interventional Radiology Annual Meeting.

More Articles on Devices:
Fixes 4 Kids Relocates to North Dakota
Victrex Target Stock Price Drops
Stryker Releases Spine Screw, Surgical Devices

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.